Mizoguchi, Taiji <br/><br/>
Oral administration of the lactic acid bacterium Pediococcus acidilactici attenuates atherosclerosis in mice by inducing tolerogenic dendritic cells.  [electronic resource] 

 -  Heart and vessels  Jun 2017 
 - 768-776 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1615-2573 
<br/><br/><label>Standard No.: </label>10.1007/s00380-017-0949-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Animals<br/>Aorta--pathology<br/>Atherosclerosis--prevention & control<br/>CD4-Positive T-Lymphocytes--immunology<br/>Dendritic Cells--immunology<br/>Female<br/>Mice<br/>Mice, Knockout, ApoE<br/>Pediococcus acidilactici<br/>Probiotics--administration & dosage